OrthoPediatrics (NASDAQ:KIDS) Stock Price Up 10.3% – Time to Buy?

OrthoPediatrics Corp. (NASDAQ:KIDS) shares shot up 10.3% during trading on Monday . The company traded as high as $20.33 and last traded at $20.1950. 82,982 shares traded hands during mid-day trading, a decline of 33% from the average session volume of 124,031 shares. The stock had previously closed at $18.31.

Wall Street Analyst Weigh In

A number of research firms have issued reports on KIDS. Lake Street Capital decreased their target price on OrthoPediatrics from $37.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, October 10th. Piper Sandler decreased their price objective on OrthoPediatrics from $30.00 to $22.00 and set an “overweight” rating for the company in a research report on Friday, October 10th. Stifel Nicolaus dropped their target price on shares of OrthoPediatrics from $32.00 to $20.00 and set a “buy” rating on the stock in a report on Friday, October 10th. Citigroup reiterated an “outperform” rating on shares of OrthoPediatrics in a report on Friday, October 10th. Finally, BTIG Research reissued a “buy” rating and set a $23.00 price objective on shares of OrthoPediatrics in a research report on Wednesday, October 29th. Eight research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $24.00.

OrthoPediatrics Trading Up 9.8%

The firm has a market cap of $504.30 million, a price-to-earnings ratio of -10.31 and a beta of 1.09. The company has a debt-to-equity ratio of 0.28, a current ratio of 7.40 and a quick ratio of 3.52. The business has a 50-day moving average of $17.63 and a 200-day moving average of $19.09.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings results on Monday, January 9th. The company reported ($0.15) EPS for the quarter. OrthoPediatrics had a negative net margin of 20.06% and a negative return on equity of 6.86%. The company had revenue of $25.08 million for the quarter. Research analysts anticipate that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

Hedge Funds Weigh In On OrthoPediatrics

Hedge funds and other institutional investors have recently bought and sold shares of the business. Tudor Investment Corp ET AL increased its position in OrthoPediatrics by 36.6% during the third quarter. Tudor Investment Corp ET AL now owns 70,935 shares of the company’s stock worth $1,314,000 after buying an additional 19,004 shares during the last quarter. Nantahala Capital Management LLC bought a new position in shares of OrthoPediatrics during the 3rd quarter worth approximately $916,000. Millennium Management LLC increased its holdings in shares of OrthoPediatrics by 20.8% during the 3rd quarter. Millennium Management LLC now owns 943,655 shares of the company’s stock worth $17,486,000 after acquiring an additional 162,628 shares during the last quarter. Aquatic Capital Management LLC raised its stake in OrthoPediatrics by 149.7% in the 3rd quarter. Aquatic Capital Management LLC now owns 17,729 shares of the company’s stock valued at $329,000 after acquiring an additional 10,629 shares during the period. Finally, Deerfield Management Company L.P. lifted its holdings in OrthoPediatrics by 1,153.4% during the 3rd quarter. Deerfield Management Company L.P. now owns 194,109 shares of the company’s stock valued at $3,597,000 after purchasing an additional 178,623 shares during the last quarter. Institutional investors own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.